StockData

BullFrog AI vs Lexaria Bioscience

BFRG and LEXX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BFRG and LEXX compare

Lexaria Bioscience is the larger company, worth 12 times as much as BullFrog AI ($109M against $9.0M).

Lexaria Bioscience scores higher on the StockData Score (8 against 3 for BullFrog AI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBFRGLEXX
Size and price
Market cap$9.0M$109M
Share price$0.488$4.41
Change, 1 year−51.2%−73.3%
Change, 5 years–−94.5%
Beta (5Y)4.870.06
Employees9134
StockData Score
Total score38 (better)
Valuation score1 (better)0
Growth score12 (better)
Performance score00
Health score16 (better)
Dividend score00
Valuation
P/S–563×
P/B1.3× (better)23.1×
FCF yield–−6.8%
Growth
Revenue growth (TTM)–−68.5%
Revenue growth, 5Y average–17.5%
Profitability
Gross margin–100%
Operating margin–−3973%
Net margin–−3986%
FCF margin–−3849%
Return on equity−131% (better)−150%
Return on invested capital–−602%
Financial health
Debt / equity–0.00
Interest coverage−1105.4×–
Current ratio10.5710.60 (better)
Altman Z-score1.34125.64 (better)
Piotroski F-score22
Dividends and buybacks
Buyback yield−111%−6.0% (better)
Shareholder yield−111%−6.0% (better)
Ownership
Held by institutions7.5%–
Held by insiders13.7%3.0%
Insider net buying, 12 months$71.5K–
Short interest, % of float–0.90%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.